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MethodologyInhibiting miRNA in Caenorhabditis elegans using a 
potent and selective antisense reagent
Genhua Zheng1, Victor Ambros2 and Wen-hong Li*1
Abstract
Background: Antisense reagents can serve as efficient and versatile tools for studying gene function by inhibiting 
nucleic acids in vivo. Antisense reagents have particular utility for the experimental manipulation of the activity of 
microRNAs (miRNAs), which are involved in the regulation of diverse developmental and physiological pathways in 
animals. Even in traditional genetic systems, such as the nematode Caenorhabditis elegans, antisense reagents can 
provide experimental strategies complementary to mutational approaches. Presently no antisense reagents are 
available for inhibiting miRNAs in the nematode C. elegans.
Results: We have developed a new class of fluorescently labelled antisense reagents to inhibit miRNAs in developing 
worms. These reagents were synthesized by conjugating dextran with 2'-O-methyl oligoribonucleotide. The dextran-
conjugated antisense reagents can be conveniently introduced into the germline of adult hermaphrodites and are 
transmitted to their progeny, where they efficiently and specifically inhibit a targeted miRNA in different tissues, 
including the hypodermis, the vulva and the nervous system. We show that these reagents can be used 
combinatorially to inhibit more than one miRNA in the same animal.
Conclusion: This class of antisense reagents represents a new addition to the toolkit for studying miRNA in C. elegans. 
Combined with numerous mutants or reporter stains available, these reagents should provide a convenient approach 
to examine genetic interactions that involve miRNA, and may facilitate studying functions of miRNAs, especially ones 
whose deletion strains are difficult to generate.
See related research article: http://jbiol.com/content/9/3/20
Background
MicroRNAs (miRNAs) are single strand RNA molecules
~ 21-23 nucleotides long that play important roles in
many biological processes through regulating gene
expression [1]. In animal cells, miRNAs act primarily by
inhibiting mRNA translation and/or stability through a
process involving partial complementary base-pairing
with sequences at the 3'-untranslated region (3' UTR).
Numerous miRNAs have been identified. To study their
functions, antisense reagents against miRNAs have been
developed as a reverse genetics tool. Synthetic oligonu-
cleotide analogues, including 2'-O-methyl oligoribonu-
cleotides [2], locked nucleic acids [3], 2'-O-methoxyethyl
oligoribonucleotides [4], and morpholinos [5], have been
tested. These antisense nucleotide analogues have been
used to knock down miRNAs in cultured cells [2-4] and
in live animals including zebrafish [5], D. melanogaster
[6] and mice [7].
Caenorhabditis elegans has long been used as a model
organism for studying the regulation and function of
small non-coding RNA molecules, and yet no antisense
reagents are available to reliably inhibit miRNAs in
worms. Such a technique would be very useful for study-
ing functions of miRNAs whose deletion strains are diffi-
cult to generate; for example, mutations causing lethality
or sterility [8]. In addition, to dissect functions of individ-
ual miRNAs that are clustered together, or to block
intronic miRNAs [8,9] without perturbing the function of
the corresponding protein-coding genes, antisense
reagents would offer a convenient approach to circum-
vent the limitation of using deletion strains.
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Results and discussion
Previous studies by Hutvagner et al. showed that anti-
sense 2'-O-methyl oligoribonucleotide injected into C.
elegans larvae could inhibit functions of a miRNA [2].
However, injection of worm larvae is technically very
demanding, and so the larval injection of anti-microRNA
oligonucleotides has not been employed for C. elegans
except the original report [2]. A much more straightfor-
ward approach would be to inject the antisense com-
pound into the syncitial gonad of hermaphrodites using
the standard injection methods employed for the DNA
transformation of C. elegans [10] so that the reagent
would inhibit a targeted microRNA during the embry-
onic and larval development of the injected hermaphro-
dite's progeny. A previous attempt at this approach using
2'-O-methyl oligoribonucleotides failed to produce the
expected phenotype [2]. We suspect that the cellular
uptake, retention or distribution properties of unconju-
gated 2'-O-methyl oligoribonucleotides might not be
optimal for an efficient inhibition of miRNA in worms.
To develop a robust antisense technique to inhibit miR-
NAs in C. elegans, we explored modifying 2'-O-methyl
oligoribonucleotides through conjugation with dextran, a
polysaccharide that is nontoxic, inert and soluble in aque-
ous solutions. Dextrans are well retained in cells over a
long period of time and dextran-dye conjugates have
been widely used for cell labelling and cell lineage tracing
[11]. To conjugate dextran with 2'-O-methyl oligoribonu-
cleotides, we first reacted dextran amines (molecular
weight 40 KDa, ~ 8 amines/dextran) with a water-soluble
bifunctional linker, MAL-dPEG4-NHS ester in order to
produce dextran- [(PEG)4-MAL]8 (Figure 1a). This thiol-
reactive intermediate was then conjugated with eight
equivalents of antisense 2'-O-methyl oligoribonucle-
otides containing a 5'-thiol group. The resulting product,
dextran-(as-2'OMelin-4)8, or D-(as-2'OMelin-4)8, contains, on
average, eight copies of 2'-O-methyl oligoribonucleotides
complementary to lin-4, the founding miRNA first identi-
fied in C. elegans [12,13].
To apply dextran-(as-2'OMelin-4)8 to inhibit lin-4 in vivo,
we injected the compound into gonads of adult hermaph-
rodites. Dextran-rhodamine (40 KDa) was coinjected as a
fluorescent marker. About 16 h after injection, we col-
lected rhodamine-labeled embryos (n = 50) under a fluo-
rescence dissection scope. When these embryos reached
adulthood, we scored for the egg laying defective (Egl)
phenotype. In C. elegans, lin-4 is required during larval
development to control the timing and pattern of cell
division in the hypodermis of larva stage 1 (L1) and stage
2 (L2). lin-4 loss of function mutants (lin-4(lf)) display
inappropriate reiterations of early fates at late develop-
mental stages and show a retarded heterochronic pheno-
type in adults in the form of the absence of adult
structures (such as vulva) and the failure of egg-laying
[12,13].
When using an injection with a concentration of 50 μM
(all concentrations refer to the total concentration of 2'-
O-methyl oligoribonucleotides in the sample as deter-
mined from the ultraviolet (UV) absorption at 260 nm)
dextran-(as-2'OMelin-4)8 was effective in inhibiting lin-4
and caused Egl in about 70% of worms (Figure 1b-d).
Raising the injection concentration to 100 μM or above
increased Egl to over 90% in the labelled worms. In con-
trast, antisense 2'-O-methyl oligoribonucleotides that is
not conjugated to dextran only had a small effect, even at
200 μM (Figure 1b). In order to examine the specificity of
dextran-(as-2'OMelin-4)8 in inhibiting lin-4, we prepared
two control dextran conjugates, dextran-(as-2'OMemiR-
237)8 and dextran-(s-2'OMelin-4)8. Dextran-(as-2'OMemiR-
237)8 contains 2'-O-methyl oligoribonucleotides comple-
mentary to miR-237, a miRNA of the lin-4 family with
similar, but not identical, sequence as lin-4. Dextran-(s-
2'OMelin-4)8 contains lin-4 sequence (sense). We did not
observe Egl phenotypes, or other abnormalities, in
worms labelled with either of these two control oligonu-
cleotides (Figure 1b) which confirmed that dextran-(as-
2'OMelin-4)8 inhibits lin-4 in a sequence specific manner,
also suggesting that worms tolerate dextran conjugates of
2'-O-methyl oligoribonucleotides fairly well.
In dextran-(as-2'OMelin-4)8, each dextran molecule is
conjugated to eight copies of antisense 2'-O-methyl oligo-
ribonucleotides. Having a high density of oligonucle-
otides on the surface of dextran molecule might increase
the steric hindrance and compromise the hybridization
efficiency of the antisense oligonucleotide to its target
miRNA. In order to test whether we could improve the
potency of these dextran conjugated antisense reagents
by varying the coupling stoichiometry, we decreased the
amount of 2'-O-methyl oligoribonucleotides used for
conjugation. In addition, we also linked a fluorescent
label (rhodamine B isothiocyanate) with dextran so that
we could visualize the distribution of these antisense
reagents directly. We prepared two rhodamine-dextran
(Rhdextran) conjugates of 2'-O-methyl oligoribonucle-
otides, Rhdextran-(as-2'OMelin-4)4 and Rhdextran-(as-
2'OMelin-4)1, by varying the equivalents of 2'-O-methyl oli-
goribonucleotides added to the conjugation reaction (Fig-
ure 2). Each Rhdextran-(as-2'OMelin-4)4 or Rhdextran-(as-
2'OMelin-4)1 on average contains four or one copy of lin-4
antisense 2'-O-methyl oligoribonucleotide, respectively
(Figures 2 and 3a). These two dextran conjugates were
comparably efficient in inhibiting lin-4, yet both were
much more potent than dextran-(as-2'OMelin-4)8. At 20 μM
or above, both Rhdextran-(as-2'OMelin-4)4and Rhdextran-(as-
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Figure 1 Inhibit miRNA in Caenorhabditis elegans using a dextran-conjugate of antisense 2'-O-methyl oligoribonucleotide. (a) Chemical syn-
thesis of dextran-(as-2'OMelin-4)8, or D-(as-2'OMelin-4)8, a dextran conjugate of an antisense reagent against lin-4. (b) Dose response of D-(as-2'OMelin-4)8 in 
causing egg laying defectives (Egl) via lin-4 inhibition. Controls include as-2'OMelin-4, a lin-4 antisense 2'-O-methyl oligoribonucleotide without dextran; 
D-(s-2'OMelin-4)8 and D-(as-2'OMemiR-237)8, dextran conjugates containing either lin-4 sense or miR-237 antisense 2'-O-methyl oligoribonucleotide. Error 
bars are standard errors of two independent injections. Each time ~ eight worms were injected and 50 or more labelled embryos from injected worms 
were scored for Egl when they reached adults. (c, d) Example images of a normal worm (c) and an Egl worm (d) labelled with dextran-(as-2'OMelin-4)8.
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2'OMelin-4)1 caused Egl in nearly 100% of labelled worms
(Figure 3b). In contrast, dextran-(as-2'OMelin-4)8 was com-
pletely ineffective at 20 μM. In addition, fluorescence
imaging of Rhdextran-(as-2'OMelin-4)1 confirmed that the
conjugate was localized fairly evenly in the cytosol after
being taken up by cells.
In order to confirm that these antisense reagents act
specifically by inhibiting lin-4, we examined several
molecular and cellular markers to characterize the devel-
opment of animals labelled with Rhdextran-(as-2'OMelin-
4)1: (1) the formation of vulval structure; (2) adult specific
alae formation and col-19 expression; and (3) the stage-
specific seam cell division programmes.
Figure 2 Synthesis of rhodamine labelled dextran conjugates of 2'-O-methyl oligoribonucleotide. During conjugation, different equivalents 
of oligoribonucleotides were used to couple with dextran to yield Rhdextran-(as-2'OMelin-4)1 or Rhdextran-(as-2'OMelin-4)4. Schematic structures of these 
products are shown at the bottom, with the heavy blue line, wavy green line and the red dot representing dextran, 2'-O-methyl oligoribonucleotide 
and rhodamine, respectively. Rh = rhodamine; RhDextran = rhodamine labeled dextran.
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The egg-laying defect of lin-4(lf ) was due to inappropri-
ate vulva development. In control animals, vulva mor-
phogenesis is evident by early L4. By mid-L4 stage, the
developing vulva displays a characteristic structure remi-
niscent of a Christmas tree (Figure 4a). In contrast, the
vulva structure was missing in a lin-4(0) mutant, lin-
4(e912) (Figure 4b). Wild type animals labelled with
Rhdextran-(as-2'OMelin-4)1 showed the similar vulvaless
anatomy as lin-4(e912) (Figure 4c), consistent with lin-4
inhibition by Rhdextran-(as-2'OMelin-4)1.
Figure 3 Coupling stoichiometry of 2'-O-methyl oligoribonucleotide affects the potency of dextran-conjugated antisense reagents. (a) 
Schematic structures of dextran-(as-2'OMelin-4)8, Rhdextran-(as-2'OMelin-4)4 and Rhdextran-(as-2'OMelin-4)1. The heavy blue line, wavy green line and the red 
dot symbolize dextran, 2'-O-methyl oligoribonucleotide and rhodamine, respectively. (b) Dose response of dextran-(as-2'OMelin-4)8, Rhdextran-(as-2'OM-
elin-4)4, and Rhdextran-(as-2'OMelin-4)1 in causing egg laying defectives. Error bars are standard errors of two independent experiments. Each time we 
scored at least 50 worms labelled with an antisense reagent.
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Besides affecting the development of vulval cells, lin-4
also controls stage-specific lateral hypodermal cell fates.
At the L4 molt, lateral seam cells exit cell cycle and form
alae. At about the same time, hypodermal cells start to
express an adult specific green fluorescence protein
(GFP) reporter, col-19::GFP (Figure 5a, b) [14,15]. Ani-
mals labelled with Rhdextran-(as-2'OMelin-4)1 (50 μM injec-
tion concentration) failed to form alae at the L4 molt
(100%, n = 20) and showed no col-19::GFP expression
(100%, n = 56; Figure 5c, d). Interestingly, 10 h later, both
col-19::GFP (100%, n = 56) and alae (100%, n = 19) were
observed in these animals (Figure 5e, f). Increasing the
dose of Rhdextran-(as-2'OMelin-4)1 (150 μM injection con-
centration) prolongs the duration of lin-4 inhibition, such
that at 10 h post-L4 molt, only 1.8% of labelled worms
showed col19::GFP (n = 55); about 60% of these animals
displayed col19::GFP 15 h later (or 25 h post-L4 molt).
These results suggest that lin-4 knockdown with Rhdex-
tran-(as-2'OMelin-4)1 caused these animals to go through
extra larval stages (L5 and L6) before they entered adult.
This is consistent with a reduction in (but not complete
elimination of ) lin-4 function.
During larval development, the lateral hypodermal
seam cells follow a characteristic division pattern. After
each division, one of the daughter cells fuses with the
hypodermis (hyp7) and the other daughter cells divides
again at a later stage until it terminally differentiates at
the L4 molt (Figure 6a) [16]. Seam cells of lin-4(e912) ani-
mals repeat the L1 fates in hypodermal cell lineages and
are unable to exit the cell cycle at the L4 molt. In order to
determine how seam cell development is altered in lin-4
knockdown animals, we followed the seam cell division
pattern by observing GFP-labelled seam cells (wIs51,
strain JR667). Both L1 and L2 divisions in lin-4 knock-
down appeared to be normal, with each V cell (including
V1 - V4 and V6) divided once in L1 (100%, n = 10, data
not shown) and twice in L2 (100%, n = 10; Figure 6b, c).
However, in early L3, V cells in lin-4 knockdown repeated
the L2 division pattern, so that each V cell gave rise to
twice as many daughter cells as the corresponding seam
cells of the control animals (100%, n = 6; Figure 6d, e).
This pattern of reiterated L2 seam cell division is consis-
tent with a reduced, but not absent, activity of lin-4, pos-
sibly resulting in an intermediate level of lin-14 over
expression [17].
Finally, since lin-4 functions through lin-14, mutations
in lin-14 should suppress the phenotype of lin-4 knock-
down. Indeed, at 20°C, inhibition of lin-4 in lin-14(n179),
a lin-14 nonnull mutant, with Rhdextran-(as-2'OMelin-4)1
(50 μM injection concentration) only caused Egl in 2.6%
of labelled worms (n = 190) and all the examined young
adult worms displayed normal alae (n = 30).
Together, these data showed that Rhdextran-(as-2'OMelin-
4)1 caused developmental retardation consistent with lin-
4 knockdown, confirming its efficacy and specificity in
inhibiting lin-4 during development.
In order to test whether these conjugated antisense
agents can be used to inhibit other miRNAs in worms, we
prepared Rhdextran-(as-2'OMelsy-6)1 and Rhdextran-(as-
2'OMelet-7)1 using the same procedure as for making
Rhdextran-(as-2'OMelin-4)1. These two dextran conjugates
were designed to block lsy-6 and let-7, respectively, two
miRNAs of known functions in C. elegans.
Figure 4 lin-4 inhibition with Rhdextran-(as-2'OMelin-4)1disrupted 
vulva formation similarly as in a lin-4(0) mutant. The vulval struc-
tures in mid-L4 (top) and in adult (bottom) are well defined in control 
animals (a). Vulva failed to form in lin-4(e912) (b) and in lin-4 knockdown 
(c). The penetrance of vulval defect in (c) was 100% (n = 45) with 50 μM 
of Rhdextran-(as-2'OMelin-4)1.
       
Figure 5 Inhibition of lin-4 with Rhdextran-(as-2'OMelin-4)1 led to re-
tarded development. (a, b) Control young adult animals (~ 55 h post-
hatching) showed normal alae [(a) highlighted by arrow heads] and 
col-19::GFP expression [(b) top - bright field; bottom - green fluores-
cence protein (GFP)]. (c-f) Young adult animals (~ 55 h post-hatching) 
labelled with Rhdextran-(as-2'OMelin-4)1 (50 μM injection concentration) 
displayed no alae (c) or col-19::GFP (d). 10 hours later (~ 65 h post-
hatching), both alae (e) and col-19::GFP (f) appeared in these animals. 
Scale bar = 0.1 mm.
? ? ?
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The lsy-6 microRNA regulates left-right asymmetry of
ASE neurons, a pair of chemosensory neurons that share
many bilaterally symmetrical features, yet differ in their
ability to discriminate different ions by expressing dis-
tinct sets of chemoreceptors of the gcy gene family [18].
lsy-6 is only present in ASEL (left ASE) of adult worms. It
promotes gcy-7 expression through repression of cog-1, a
transcription factor that negatively regulates gcy-7
expression [18]. In order to score the inhibition of lsy-6
activity, we used two reporter strains expressing GFP in
either ASEL (gcy-7prom::gfp, strain OH3191) or ASER
(right ASE; gcy-5prom::gfp, strain OH3192). Rhdextran-(as-
2'OMelsy-6)1 was highly effective in inhibiting lsy-6. At the
injection concentration of only 3 μM, the compound
inhibited lsy-6 with nearly 100% penetrance, assayed by
the repression of gcy-7prom::gfp expression in ASEL (Fig-
ure 7a), and by the induction of ectopic gcy-5prom::gfp
expression in ASEL (Figure 7b).
Another miRNA, let-7, controls the larval-to-adult
transition by repressing the translation of lin-41 and hbl-
1. Mutations in let-7 lead to a retarded terminal differen-
tiation of seam cells, which results in the elimination of
alae and a bursting of the animal at the vulva as the ani-
mal undergoes the fourth molt [19]. We observed a dose-
dependent bursting or no-alae phenotype, consistent
with inhibition of let-7 activity in the progeny of her-
maphrodites injected with Rhdextran-(as-2'OMelet-7)1 (Fig-
ure 8). When Rhdextran-(as-2'OMelet-7)1 was injected at 20
μM, it caused bursting vulva in about 40% of labelled
worms and eliminated the formation of alae in nearly 80%
of worms. Raising the concentration of Rhdextran-(as-
2'OMelet-7)1 to 50 μM or above increased the penetrance,
and none of the labelled animals showed alae when they
reached young adults. In contrast, an injection of Rhdex-
tran-(as-2'OMemir-84)1 directed against another let-7 fam-
ily microRNA caused no observable phenotype. Since
mir-84 mutations do not cause visible phenotypes [20],
this result is consistent with these antisense reagents
inhibiting the targeted miRNA with high specificity. Fur-
ther, in a lin-41 nonnull mutant, lin-41(ma104), Rhdex-
tran-(as-2'OMelet-7)1 (50 μM) failed to produce the bursting
Figure 6 lin-4 knockdown caused repetition of L2 seam cell divi-
sion pattern in L3. (a) Seam cell lineage for V1 - V4 and V6 of wild type, 
lin-4(0) and lin-4 knockdown by Rhdextran-(as-2'OMelin-4)1 at 50 μM injec-
tion concentration. (b, c) In early L2, each N2 seam cell gave rise to a 
quartet of daughter cells after two successive divisions in both N2 (b) 
and in lin-4 knockdown (c). (d, e) In early L3, each Vn cell of lin-4 knock-
down repeated L2 programme, giving rise to twice as many daughter 
cells (e) as those of control animals (d). Each image is representative of 
at least six animals (see text). Scale bar = 20 μm.
 
 
  
 
 
  
 
Figure 7 Inhibit lsy-6 in neuronal cells with a dextran conjugated 
antisense reagent. (a) Dose response of Rhdextran-(as-2'OMelsy-6)1 in re-
pressing gcy-7prom::gfp expression in ASEL(left ASE). (b) Dose response 
of Rhdextran-(as-2'OMelsy-6)1 in causing ectotopic gcy-5prom::gfp expres-
sion in ASEL. L = left; R = right; A = anterior; P = posterior.
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vulva or alae defect in labelled worms (n = 12). This again
suggested that these antisense reagents acted specifically
by blocking their corresponding microRNAs.
In order to confirm that this class of antisense reagents
is also effective in inhibiting microRNAs during embryo
development, we prepared Rhdextran-(as-2'OMemir-42)1
against mir-42, a member of the mir-35 family which
consists of eight microRNA genes of similar sequences.
This family of microRNAs is expressed only during
embryogenesis [21] and functions redundantly to control
embryonic development [8,22]. Deletion of the seven
microRNAs (mir35 - 41, strain MT14119) leads to a tem-
perature-sensitive late embryonic or L1 lethal phenotype.
At 15°C, about 10% of the embryos displayed this pheno-
type, while the remaining 90% developed normally (Fig-
ure 9). In this mir35-41 null background, inhibition of
mir-42 with Rhdextran-(as-2'OMemir-42)1 dramatically
increased embryonic or L1 lethality: at the injection con-
centration of 3 μM, 77% of labelled worms were embry-
onic or L1 lethal. In contrast, inhibition of mir-42 had
little effect in N2 strain (Figure 9).
Among four miRNAs tested (lin-4, lsy-6, let-7 and mir-
42), the dose of antisense reagents required for the effec-
tive inhibition of individual miRNA varied from as low as
three micromolar (lsy-6 and mir-42) to as high as tens of
micromolar (let-7). Two factors may account for the dif-
ference in the apparent potency of these antisense
reagents. First, the cellular expression level of different
miRNAs varies over a wide range [23], so a higher con-
centration of antisense reagents is needed to block more
abundant miRNAs. Second, to inhibit a miRNA that is
expressed late in larval development, it would require a
higher concentration of reagent in the zygote to compen-
sate for the dilution effect of cell division and larval
growth. let-7, for example, is not expressed until the third
larval stage and functions in the fourth stage [19]. By that
time, the antisense reagent would be further diluted as
animals grow and expand in size. In principle, a higher
concentration of antisense reagents can be used to over-
come the dilution effect. However, it should be cautioned
that, as we raised the dose, we also noticed that an
increasing number of embryos failed to hatch at concen-
trations above 50 μM. The extent to which these anti-
sense reagents affect embryo development seemed to
vary. Among the reagents tested, antisense reagents (anti-
mirs) against lin-4 and mir-237 were best tolerated, with
nearly 100% of the embryos hatched normally at 100 μM.
By comparison, the antimir against let-7 was least toler-
ated, with close to 40% of embryos hatched at 100 μM
(Figure 10). We have not yet explored the causes for this
differential effect, although we anticipate that the future
development of other bioconjugates employing different
classes of oligonucleotides, for example locked nucleic
acids or 2'-O-methoxyethyl oligoribonucleotides, may
offer an improvement on the potency with concomitant
reduction of the perturbation on embryo development.
In order to test whether these antisense reagents can be
used combinatorially to inhibit more than one miRNAs at
a time, we coinjected Rhdextran-(as-2'OMelsy-6)1 and Rhdex-
tran-(as-2'OMelin-4)1 into gonads of OH3192 strain (gcy-
5prom::gfp). Together, these two reagents caused Egl in all
labelled worms and they induced ectopic gcy-5prom::gfp
expression in ASEL (Figure 11). In contrast, Rhdextran-(as-
2'OMelin-4)1 alone did not alter the expression pattern of
gcy-5prom::gfp, and Rhdextran-(as-2'OMelsy-6)1 by itself failed
to cause Egl (Figure 11). The results again confirmed the
specificity of these dextran-conjugated antisense reagents
and suggested that multiple antisense reagents can be
used in combination to block more than one miRNAs in
Figure 8 Inhibit let-7 with Rhdextran-(as-2'OMelet-7)1. (a) Dose re-
sponse of dextran-(as-2'OMelet-7)1 in causing bursting vulva or no alae 
formation. Error bars are standrad errors of two independent injec-
tions. After each injection, 50 or more embryos from injected worms 
were randomly picked and scored for bursting vulva or absense of alae 
when they reached adults. (b) An example image showing the burst-
ing vulva phenotype.
 
Figure 9 Inhibit mir-42 with Rhdextran-(as-2'OMemir-42)1 during em-
bryogenesis. Error bars are standard errors of two independent exper-
iments performed at 15°C. Each time we scored at least 50 worms 
labeled with an antisense reagent. MT14119 contains a deletion of 
1261 bases on chromosome II which removes mir-35 - mir-41 (ref. [8]).
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C. elegans. As numerous deletion strains of single miRNA
genes appear to be grossly normal, it has been suggested
that redundancy might mask their functions [8]. Mixing
these antisense reagents would allow the study of the
combinatorial effects of multiple miRNAs on gene
expression and should facilitate screening genetic inter-
actions using mutants or reporter strains.
Conclusions
We have developed a new class of antisense reagents that
potently and selectively inhibit miRNAs in C. elegans.
This offers an experimental approach complementary to
mutational strategy for the study of the functions of
miRNA in vivo.
Methods
General methods
2'-O-methyl oligoribonucleotides were either purchased
from the Integrated DNA Technologies (IDT, Iowa, USA)
or synthesized in-house by the standard solid phase phos-
phoramidite chemistry using an ABI 394 DNA/RNA Syn-
thesizer (Applied Biosystems, California, USA).
Sequences of 2'-O-methyl oligoribonucleotides used in
this study are:
s-2'OMelin-4 (sense): 5' - UCCCUGAGACCUCAAGU-
GUGA - 3'
as-2'OMelin-4 (antisense): 5' - UCACACUUGAGGUCU-
CAGGGA - 3'
as-2'OMemiR-237: 5' - AGCUGUUCGAGAAUUCU-
CAGGGA - 3'
as-2'OMelet-7: 5' - AACUAUACAACCUACUACCUCA -
3'
as-2'OMelsy-6: 5' - CGAAAUGCGUCUCAUACAAAA -
3'
as-2'OMemiR-84: 5' - UACAACAUUACAUACUAC-
CUCA - 3'
as-2'OMemiR-42: 5' - UCUGUAGAUGUUAACCCG-
GUGA - 3'
For bioconjugation, an n-hexyl linker containing a dis-
ulfide bond (Thio-Modifier C6 S-S, Glen Research, Vir-
ginia, USA) was attached to the 5'-end of 2'-O-methyl
oligoribonucleotides. A,C,G,U-2'-OMe-RNA CE phos-
phoramidite monomers and A,C,G,U-2'-OMe RNA syn-
thesis supports were from AZCO Biotech (California,
USA). MAL-dPEG4 ™-NHS ester was from Quanta
BioDesign Ltd (Ohio, USA). Dextran amine (40 KD) was
purchased from Molecular Probes (Oregon, USA). Other
reagents and solvents were from Aldrich (Missouri,
USA). The UV and visible absorption spectra were
recorded on a Shimadzu 2401 PC spectrometer.
Conjugating 2'-O-methyl oligonucleotides with dextran
To prepare Rhdextran-(as-2'OMelin-4)1, for example, dex-
tran amine (40 KD, ~ 8 amines/dextran, 10 mg) was first
reacted with Rhodamine B isothiocyanate (RBITC, 0.4
mg, 0.75 μmol) in 0.1 mL anhydrous DMSO at 37°C for 8
h. MAL-dPEG4-NHS ester (3 mg, 5.84 μmol) was then
added and the reaction was continued at room tempera-
ture overnight. The reaction mixture was dialyzed against
water through a regenerated cellulose membrane (Float A
Lyzer®, molecular wight cut off [MWCO] = 3500, Spec-
trum Laboratories, Inc. California, USA) to remove
excess reagents. After freeze drying, the solid product
was dissolved in water (0.25 mL) to make a 1 mM rhod-
amine-dextran stock solution.
To conjugate 2'-O-methyl oligoribonucleotides con-
taining a 5'-disulfide (5' S-S) group with rhodamine-dex-
tran, we first reduced the 5'-disulfide group to a free thiol
using tris(2-carboxyethyl) phosphine (TCEP), a water sol-
uble reducing reagent. as-2'OMelin-4 (5' S-S, 30 nmol) was
dissolved in 100 μl of deaerated sodium phosphate buffer
(100 mM, pH = 7.0). An excess amount of TCEP was
added to the solution under the protection of Argon. One
hour later, cold ethanol (0.5 mL) was added to precipitate
the oligonucleotide. The supernatant was removed after
centrifugation (14000 rpm for 10 min) and the precipi-
tated oligonucleotide was redissolved in a sodium phos-
phate buffer (100 mM, pH 7.0, 70 μL). The
oligonucleotide solution was then mixed with the rhod-
amine-dextran stock solution (30 μL) prepared above.
Figure 10 Variation of percentage of hatched embryos labeled 
with different doses of antisense reagents. Rhodamine-dextran (Rh-
Dextran) or its conjugates of antisense 2'-O-methyl oligoribonucle-
otides against let-7, lin-4, lsy-6, mir-237 were injected into gonads of N2 
worms at three different concentrations. Each time we collected 50 or 
more labelled embryos and counted hatched larvae the next day. Error 
bars are standard errors of two independent injections. Examination of 
embryos that failed to hatch revealed that most of them were arrested 
around 50-cell stage. Embryos, once hatched, developed into adults 
that appeared to be grossly normal.
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Figure 11 Concurrent inhibition of lin-4 and lsy-6 in Caenorhabditis elegans with two antisense reagents. (a) Rhdextran-(as-2'OMelin-4)1 (50 μM) 
or Rhdextran-(as-2'OMelsy-6)1 (20 μM), or a mixture of both reagents, were injected into gonads of OH3192 strain (gcy-5prom::gfp). The egg laying defective 
(Egl) and ectopic expression of gcy-5prom::gfp in ASEL (left ASE) were scored (n = 50 worms. Error bars are standard errors of two independent injection 
experiments). (b, c) Bright field [(b) showing Egl] and fluorescence [(c) showing ectopic expression of gcy-5prom::gfp in ASEL] images of a worm 
(OH3192) labelled with both Rhdextran-(as-2'OMelin-4)1 and Rhdextran-(as-2'OMelsy-6)1.
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The mixture was stirred under argon overnight. Excess
mercaptoethanol was added to cap the remaining unre-
acted maleimide group. The reaction mixture was dia-
lyzed against water using a cellulose membrane (MWCO
= 10,000) and lyophilized to yield the final product. The
dried product was re-dissolved in water to prepare a
stock solution. The concentration of stock solution was
typically in the range of 1 mM which was determined by
measuring the UV absorption of 2'-O-methyl oligoribo-
nucleotide at 260 nm. The UV absorption was converted
to the oligonucleotide concentration using the OligoAna-
lyzer program accessible online http://www.idtdna.com/
analyzer/Applications/OligoAnalyzer/. Rhodamine
absorption at 260 nm was corrected according to its peak
absorption at 559 nm. The conjugation yields were typi-
cally around 50%. The average stoichiometry of conjuga-
tion was calculated from the total amount of
oligoribonucleotide in the final product divided by the
amount of dextran added to the reaction.
RhDextran-(as-2'OMelin-4)4, dextran-(as-2'OMelin-4)8 and
other dextran conjugates containing different sequences
of 2'-O-methyl oligonucleotides were synthesized simi-
larly. When preparing RhDextran-(as-2'OMelin-4)4, four
equivalents of 2'-O-methyl oligonucleotides containing a
5'-disulfide group were used to react with the dextran-
linked maleimide group. No Rhodamine B isothiocyanate
was used when synthesizing dextran-(as-2'OMelin-4)8.
Conjugation products purified by dialysis still con-
tained a small amount of unconjugated oligonucleotides
as analyzed by the polyacrylamide gel electrophoresis
(PAGE), and were used for most of the experiments
except for the ones shown in Figure 8 and Figure 10. To
completely remove unconjugated oligonucleotides from
dextran-conjugates, the reaction mixture was first con-
centrated under vacuum to a small volume (≤30 μL) and
then mixed with 0.27 mL formamide (>99%, Ambion,
Texas, USA). The mixture was boiled briefly and loaded
into 5% preparative denaturing polyacrylamide gel. After
running the gel at 400 V for 10 min, we confirmed the
separation of free 2'-O-methyl oligoribonucleotides from
dextran conjugates by viewing the gel over a fluorophore-
coated thin-layer chromatography plate (Silica Gel 60,
F254, Merck, Germany) under the UV illumination (265
nm). Dextran-conjugated products that remained near
the origin of the gel showing red fluorescence were cut
out and transferred into a dialysis membrane (MWCO =
1000) containing 2 mL of 0.5× TBE buffer (Bio-Rad, CA,
USA). The dialysis membrane was sealed and the product
in the gel was recovered by electrophoresis (300 V for 20
min). The TBE buffer in the dialysis membrane contain-
ing dextran conjugates was transferred to another cellu-
lose dialysis membrane (MWCO = 10000) and dialyzed
against water 3 times over 16 hrs to remove salts and
urea. The final products were obtained as a powder after
lyophilization.
Worm injection and assay of miRNA inhibition in vivo
Dextran conjugates of 2'-O-methyl oligoribonucleotides
were injected into both gonads of young adult worms of
either wild-type (N2) or transgenics expressing GFP in an
ASE neuron (OH3191 or OH 3192). Rhodamine dextran
(40 KD, 8 mg/mL final concentration) was included in the
injection solution if the injected reagents contained no
fluorescent label, for example, dextran-(as-2'OMelin-4)8 or
unconjugated 2'-O-methyl oligoribonucleotides. For each
experiment, we routinely injected a sample into ~ eight
worms. About 16 h later, we collected rhodamine labelled
embryos (n = 50) laid by injected worms under a fluores-
cence dissection scope (SteREO Discovery.V12, Carl
Zeiss, Göttingen, Germany), and scored their phenotypes
when they reached appropriate larval or adult stages.
Staging of animal development was based on gonad size
and morphology.
We also attempted delivering antisense reagents using a
standard soaking method for RNAi ([24]. However, this
method turned out to be ineffective. After incubating L1
larvae with Rhdextran-(as-2'OMelin-4)1 (300 μM) or Rhdex-
tran-(as-2'OMelet-7)1 (300 μM) for 48 h in the soaking solu-
tion (M9 solution (0.25 ×, without Mg2+) with 3 mM
spermidine and 0.05% gelatin), we recovered L1 larvae on
NGM plates. All the worms developed normally without
showing any observable phenotype expected from lin-4
or let-7 knockdown.
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